In line with previous results, astrocyte-specific ablation of Nedd4 led to a significant downregulation of YAP1 protein levels (Fig
The TRIUMPH-4 trial showed generally mild gastrointestinal side effects that infrequently led to discontinuation
Background on Semaglutide and the GLP-1 Market in China Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, mimics the GLP-1 hormone to regulate blood sugar, slow gastric emptying, and reduce appetite, leading to significant weight loss and cardiovascular benefits
Traditionally, NDD pathogenesis has been viewed through a neurocentric lens focusing on protein misfolding, synaptic dysfunction, and central immune activation [3]
NTZ effects were dose-dependent, where the higher dose was more efficient and closer to the effect of NAC or 4-PBA